Hyaluronate Injection for Lateral Epicondylitis

Status Completed

Clinical Trial Summary

This proposal is a prospective, randomized, double-blinded study to evaluate the efficacy of hyaluronic acid (HA) injections for chronic lateral epicondylitis (LE). HA has traditionally been used to treat knee osteoarthritis. There are a small number of studies in the literature that suggest that HA injections can be very effective for tendinosis. Although LE has been studied with literally hundreds of articles published, very little treatment has proven to be efficacious. This study will investigate the effectiveness of hyaluronate in treatment of chronic LE. This will include a two arm study with one formulation of HA tested against saline injections as the control.

Clinical Trial Description

Patients will be randomized and blinded into one of the two arms. Patients will receive 3 injections total spaced over a 4 week period. After the injections are completed, patients will return for evaluation at 3, 6 and 12 months from the initial injection. A total of 72 patients will be divided into the 2 groups. The questionnaires will be administered by a research assistant blinded to the randomization. Three different outcomes measures will be collected, all patient-oriented including the Patient Rated Tennis Elbow Evaluation (PRTEE), Visual Analog Score (VAS) for pain while at rest and with maximum grip, and the short form Disabilities of the Arm, Shoulder and Hand (quickDASH).

The primary outcome measure will be the VAS for pain at 3 months from the initial injection. All measures will be evaluated at baseline then again at 12 months from the initial injection.

HA formulation will be Intragel (IBSA) which include 2cc with a concentration of 16mg per 2cc. The molecular weight with Intragel averaging 800-1200 kiloDaltons.

The syringes will be coded and the injections blinded. The injections will be given 1cm distal to the lateral epicondyle at the site of maximum tenderness. The needle will be introduced to the depth of the bone then withdrawn 1-2mm. The injection will be given in two locations in and around the point of maximum tenderness. ;

Study Design

Related Conditions & MeSH terms

Tennis Elbow

Clinical Trial Details

NCT number	NCT02258295
Study type	Interventional
Source	Shaare Zedek Medical Center
Contact
Status	Completed
Phase	Phase 3
Start date	January 18, 2017
Completion date	September 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02861183` - Study of Sodium Hyaluronate to Provide Symptomatic Relief of Lateral Epicondylosis (Tennis Elbow)	N/A
Recruiting	`NCT02304952` - Eccentric Exercise or Radiofrequent Microtenotomy as Treatment of Lateral Epicondylalgia	N/A
Completed	`NCT02596659` - Effectiveness of Radial Extracorporeal Shockwave Therapy on Tennis Elbow	N/A
Completed	`NCT00674622` - Prolotherapy for the Treatment of Chronic Lateral Epicondylitis	Phase 2/Phase 3
Completed	`NCT06206109` - The Effect of Tendon Tears on Lateral Epicondylitis
Recruiting	`NCT04442321` - Ultrasound-Guided Percutaneous Electrical Stimulation on Radial Nerve in Patients With Lateral Epicondylalgia	N/A
Not yet recruiting	`NCT04382144` - Levobupivacaine Versus Liposomal Bupivacaine (Exparel®) for Treatment of Pain and Disability in Lateral Epicondylitis	Phase 4
Recruiting	`NCT03863847` - A Neurofeedback Treatment for Chronic Musculoskeletal Pain	N/A
Completed	`NCT04576195` - Immediate Neurophysiological Effects of PENS on Radial Nerve in Patients With Lateral Epicondylalgia	N/A
Recruiting	`NCT02343809` - Diacutaneous Fibrolysis on Lateral Epicondylitis	Phase 3
Completed	`NCT05084664` - Effect of Premodulated Current Versus Diadynamic Current On the Management of Tennis Elbow.	N/A
Completed	`NCT05039827` - Mobilition With Movement and Soft Tissue Mobiiztion in Tennis Elbow	N/A
Recruiting	`NCT00395616` - Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow	N/A
Completed	`NCT00130949` - ALGRX 4975 in the Treatment of Tennis Elbow	Phase 2
Recruiting	`NCT06116175` - Lateral Epicondylitis Continuous Radiofrequency Microtenotomy	N/A
Recruiting	`NCT05326763` - Functional and Electromyographical Changes After PRP or Dextrose Injection in Chronic Lateral Epicondylitis	Phase 3
Completed	`NCT04454060` - Study on the Development of Arthroscopic Treatment of Refractory Tennis Elbow
Enrolling by invitation	`NCT04445727` - Efficacy of Vitamin C Supplement vs Spinal Manipulation to Treatment in Lateral Epicondylitis	N/A
Completed	`NCT04454047` - Extracapsular Arthroscopic Treatment for Refractory Tennis Elbow——Mid-and-short Term Retrospective Study of 50 Cases
Recruiting	`NCT06382805` - Comparison of the Effects of Kinesio Tape and High-intensity Laser Therapy in Lateral Epicondylitis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.